U.S. Markets close in 4 hrs 9 mins

AbbVie Stock Is Poised To Become A Top 5 Pharma — But Should You Buy It?

ALLISON GATLIN
AbbVie Stock Is Poised To Become A Top 5 Pharma — But Should You Buy It?

AbbVie stock fell on its $63 billion plan to acquire Botox-maker Allergan, which helps the pharmaceutical company diversify as Humira patents expire. So, is ABBV stock a buy right now?